I agree that this site is using cookies. You can find further informations here.
X
Severgnini, Luciano
18  results:
Search for persons X
?
1

Efficacy and safety of tixagevimab/cilgavimab as passive im..:

Reimann, Patrick ; Petzer, Verena ; Mündlein, Axel...
Annals of Hematology.  103 (2024)  6 - p. 2123-2131 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Cell-free circulating RAS mutation concentrations significa..:

Muendlein, Axel ; Geiger, Kathrin ; Heinzle, Christine...
Journal of Cancer Research and Clinical Oncology.  149 (2023)  9 - p. 6435-6444 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Correlation between the level of evidence and the class of ..:

Milbradt, Stephan ; Eichhorn, Jürg ; Fetzner, Ulrich...
International Journal of Cardiology.  375 (2023)  - p. 119-123 , 2023
Link: https://doi.org/10.1016/..
 
?
4

SARS-CoV-2-related mortality and treatment delays for cance..:

Berger, Julia M. ; Wohlfarth, Phillipp ; Königsbrügge, Oliver...
Wiener klinische Wochenschrift.  134 (2022)  9-10 - p. 371-376 , 2022
Link: https://doi.org/10.1007/..
 
?
5

SARS-CoV-2 RBD-specific and NP-specific antibody response o..:

Atzl, Michele ; Muendlein, Axel ; Winder, Thomas...
BMJ Open.  12 (2022)  5 - p. e052130 , 2022
Link: https://doi.org/10.1136/..
 
?
6

Circulating syndecan-1 and glypican-4 predict 12-month surv..:

Muendlein, Axel ; Severgnini, Luciano ; Decker, Thomas...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
7

Serological SARS‐CoV‐2 antibody response, potential predict..:

Benda, Magdalena ; Mutschlechner, Beatrix ; Ulmer, Hanno...
British Journal of Haematology.  195 (2021)  4 - p. 523-531 , 2021
Link: https://doi.org/10.1111/..
 
?
8

Efficacy and safety of heterologous booster vaccination wit..:

Reimann, Patrick ; Ulmer, Hanno ; Mutschlechner, Beatrix...
British Journal of Haematology.  196 (2021)  3 - p. 577-584 , 2021
Link: https://doi.org/10.1111/..
 
?
9

Circulating syndecan-1 and glypican-4 predict 12-month surv..:

Muendlein, Axel ; Severgnini, Luciano ; Decker, Thomas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638102/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

SARS-CoV-2 RBD-specific and NP-specific antibody response o..:

Alois Lang ; Axel Muendlein ; Heinz Drexel...
https://bmjopen.bmj.com/content/12/5/e052130.full.  , 2022
Link: https://doi.org/10.1136/..
 
?
11

Circulating syndecan-1 and glypican-4 predict 12-month surv..:

Axel Muendlein ; Luciano Severgnini ; Thomas Decker...
https://www.frontiersin.org/articles/10.3389/fonc.2022.1045995/full.  , 2022
Link: https://doi.org/10.3389/..
 
?
12

DataSheet_1_Circulating syndecan-1 and glypican-4 predict 1..:

Axel Muendlein ; Luciano Severgnini ; Thomas Decker...
doi:10.3389/fonc.2022.1045995.s001.  , 2022
Link: https://doi.org/10.3389/..
 
?
13

BRAF mutations and survival with surgery for colorectal liv..:

Petrelli, Fausto ; Arru, Marcella ; Colombo, Silvia...
European Journal of Surgical Oncology.  50 (2024)  6 - p. 108306 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Strategies for comparing gene expression profiles from diff..:

Severgnini, Marco ; Bicciato, Silvio ; Mangano, Eleonora...
Analytical Biochemistry.  353 (2006)  1 - p. 43-56 , 2006
Link: https://doi.org/10.1016/..
 
?
15

Noninvasive positive pressure ventilation delivered by helm..:

Chiumello, Davide ; Pelosi, Paolo ; Carlesso, Eleonora...
Intensive Care Medicine.  29 (2003)  10 - p. 1671-1679 , 2003
Link: https://doi.org/10.1007/..
 
1-15